NASDAQ:CBMG

Delisted

Cellular Biomedicine Group Stock News

Buy CBMG

*Your capital is at risk

$19.75

+0 (+0%)

At Close: May 27, 2022

46 Biggest Movers From Friday

12:00am, Monday, 01'st Oct 2018

Cellular Biomedicine Shares To Resume Trade At 8 a.m. EDT

12:00am, Thursday, 27'th Sep 2018

Stocks Which Set New 52-Week High Yesterday, September 25th

12:00am, Wednesday, 26'th Sep 2018

Cellular Biomedicine Gr Q2 EPS $(0.53) Down From $(0.43) YoY, Sales $77.313K Up From $62.914K YoY

12:00am, Wednesday, 08'th Aug 2018

Stocks Which Set New 52-Week High Yesterday, August 1st

12:00am, Thursday, 02'nd Aug 2018

After Hours Gainers / Losers (06/22/2018)

12:00am, Friday, 22'nd Jun 2018

Forensic Value Algorithm Stock Selections - June

12:00am, Saturday, 16'th Jun 2018

Maxim Group Terminates Cellular Biomedicine Gr Coverage

12:00am, Friday, 15'th Jun 2018

Cellular Biomedicine Reports Q1 EPS $(0.51), Sales $50.96M

12:00am, Tuesday, 08'th May 2018

Cellular Biomedicine Group Announces 'Positive' 48-Week Clinical Data of AlloJoin Human Adipose-Derived Mesenchymal Progenitor Cell Knee Osteoarthritis China Phase I Trial

12:00am, Friday, 16'th Mar 2018

Cellular Bio to present AlloJoin data at China conference tomorrow

12:00am, Wednesday, 14'th Mar 2018

Cellular Biomedicine reports FY results

12:00am, Tuesday, 06'th Mar 2018

Cellular Biomedicine Group S-3 Filing Shows Registration For ~2.93M Share Common Stock Offering Via Selling Holders

12:00am, Monday, 05'th Mar 2018

Cellular Biomedicine Group Stock News

46 Biggest Movers From Friday

Cellular Biomedicine Shares To Resume Trade At 8 a.m. EDT

Stocks Which Set New 52-Week High Yesterday, September 25th

Cellular Biomedicine Gr Q2 EPS $(0.53) Down From $(0.43) YoY, Sales $77.313K Up From $62.914K YoY

Stocks Which Set New 52-Week High Yesterday, August 1st

After Hours Gainers / Losers (06/22/2018)

Forensic Value Algorithm Stock Selections - June

Maxim Group Terminates Cellular Biomedicine Gr Coverage

Cellular Biomedicine Reports Q1 EPS $(0.51), Sales $50.96M

Cellular Biomedicine Group Announces 'Positive' 48-Week Clinical Data of AlloJoin Human Adipose-Derived Mesenchymal Progenitor Cell Knee Osteoarthritis China Phase I Trial

Cellular Bio to present AlloJoin data at China conference tomorrow

Cellular Biomedicine reports FY results

Cellular Biomedicine Group S-3 Filing Shows Registration For ~2.93M Share Common Stock Offering Via Selling Holders

Sailing Capital Overseas Investments Fund Reports 10.1% Stake In Cellular Biomedicine

8 Stocks Moving In Wednesday's After-Hours Session

Top Fintech Company